'India will play a vital role in global clinical research market'
Healthcare Radius|April 2023
With the need for rapid rollout of new drugs, the clinical trials segment has seen several new trends such as technology adoption, decentralized trials, and so on. In an interview to Nagesh Joshi, Krutikesh Age, Co-founder, DPHS elaborates the latest trends in this space and how the segment will look like in the near future. Excerpts of the interview:
Krutikesh Age
'India will play a vital role in global clinical research market'

Q. What are the trends in India's clinical trials market?

The regulatory authorities have become stringent in enforcing safety and ethical standards in clinical trials. Sponsors and CROS are now investing more in quality control measures to ensure compliance with these standards. Digital technologies such as electronic data capture (EDC), e-consent, and telemedicine are being increasingly used in clinical trials in India. These technologies not only improve data accuracy and patient safety but also reduce costs and increase efficiency.

The COVID-19 pandemic has accelerated the adoption of decentralized trials in India. Sponsors and CROS are exploring innovative ways to conduct trials remotely, such as home-based monitoring and virtual site visits. There also is a growing trend towards the emergence of niche CROs in India that specialize in specific therapeutic areas. These CROS have knowledge and expertise in their respective areas and they aim at provide better value to sponsors.

Collaboration between academia, industry, and government is growing in India. There is a focus on developing strategic partnerships to drive innovation and bring new drugs to the market faster.

There is a growing focus on patient centricity. Companies are involving patients in the design of their trials, seeking feedback to ensure that their trials are conducted in a patient-friendly manner.

Q. What has been the impact of Covid-19?

The COVID-19 pandemic has had a significant impact on the clinical trials scenario in India. The pandemic has disrupted the conduct of clinical trials globally, including in India. Due to lockdowns and restrictions on travel, many clinical trial sites were temporarily closed, resulting in delays in ongoing trials.

This story is from the April 2023 edition of Healthcare Radius.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the April 2023 edition of Healthcare Radius.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM HEALTHCARE RADIUSView All
Bhuvan Bam launches sexual wellness brand Peppy
Healthcare Radius

Bhuvan Bam launches sexual wellness brand Peppy

Peppy has partnered with the popular digital content creator and actor Bhuvan Bam, who joins as both a co-founder and an investor.

time-read
1 min  |
January 2025
KimsHealth inaugurates Linear Accelerator for Radiotherapy
Healthcare Radius

KimsHealth inaugurates Linear Accelerator for Radiotherapy

The TrueBeam technology enables doctors to effectively deliver radiation to even the most challenging cancer-affected areas of the body.

time-read
1 min  |
January 2025
Dr. Reddy's launches Toripalimab for nasopharyngeal carcinoma
Healthcare Radius

Dr. Reddy's launches Toripalimab for nasopharyngeal carcinoma

Dr. Reddy’s obtained exclusive rights to develop and commercialize Toripalimab in 21 countries including India, South Africa, Brazil and some countries in Latin America.

time-read
1 min  |
January 2025
Red.Health and Medanta launch UP's first 5G ambulance
Healthcare Radius

Red.Health and Medanta launch UP's first 5G ambulance

5G ambulances use SyncX infrastructure to transmit critical patient data to hospital ER teams with less than two seconds of latency.

time-read
1 min  |
January 2025
THE MODERN EVOLUTION OF AYURVEDA: A TIMELESS APPROACH TO HEALTH
Healthcare Radius

THE MODERN EVOLUTION OF AYURVEDA: A TIMELESS APPROACH TO HEALTH

By integrating Ayurveda with modern healthcare and building advanced facilities, India can create a hybrid model that delivers quality care to underserved populations while preserving its heritage.

time-read
2 mins  |
January 2025
BOOSTING INDIA'S MEDICAL EQUIPMENT MANUFACTURING
Healthcare Radius

BOOSTING INDIA'S MEDICAL EQUIPMENT MANUFACTURING

A well-structured budget can redefine the healthcare ecosystem, enabling synergies between hospitals, medtech, logistics, and pharma industries.

time-read
1 min  |
January 2025
HEALTHCARE SECTOR EYES MAJOR REFORMS AND HIGHER ALLOCATION
Healthcare Radius

HEALTHCARE SECTOR EYES MAJOR REFORMS AND HIGHER ALLOCATION

By addressing critical priorities, tackling challenges, and aligning with expert insights, this budget can pave the way for a healthier and more resilient India

time-read
2 mins  |
January 2025
EVOLVING HEALTHCARE LANDSCAPE FOR FUTURE NECESSITIES
Healthcare Radius

EVOLVING HEALTHCARE LANDSCAPE FOR FUTURE NECESSITIES

The integration of digital health solutions will facilitate better patient tracking and data management leading to improved healthcare outcomes

time-read
2 mins  |
January 2025
STRATEGIC INVESTMENTS & REFORMS EXPECTED
Healthcare Radius

STRATEGIC INVESTMENTS & REFORMS EXPECTED

Shifting hospitals from the GST exemption category to zero-tax would allow input credit, lowering treatment costs for patients.

time-read
2 mins  |
January 2025
BUDGET 2025-26 KEY EXPECTATIONS
Healthcare Radius

BUDGET 2025-26 KEY EXPECTATIONS

Industry leaders have shared their expectations for the upcoming budget, emphasizing the need for comprehensive reforms in areas ranging from medical education and skill development to insurance accessibility and technological innovation.

time-read
2 mins  |
January 2025